Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses

Antiviral Research

Volumn 88, Issue 2, 2010, Pages 182-186

  Dharan, Nila J ^a,b   Beekmann, Susan E ^c   Fiore, Anthony ^a   Finelli, Lyn ^a   Uyeki, Timothy M ^a   Polgreen, Philip M ^c   Fry, Alicia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Antiviral resistance; Antiviral use guidelines; Influenza; Physician education

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DISEASE SURVEILLANCE; HEALTH SURVEY; HUMAN; INFLUENZA VIRUS; INFLUENZA VIRUS A; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEASONAL INFLUENZA;

ADAMANTANE; ANTIVIRAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; DRUG UTILIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RIMANTADINE; SEASONS; ZANAMIVIR;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 77958151099     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.08.010     Document Type: Article

References (15)

1. CDC High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents-United States, 2005-06 influenza season. Morb. Mortal. Wkly. Rep. 2006, 55(January (2)):44-46.
2. CDC Influenza activity-United States and worldwide, 2007-08 season. Morb. Mortal. Wkly. Rep. 2008, 57(June (25)):692-697.
3. CDC Update: influenza activity-United States, September 28-November 29, 2008. Morb. Mortal. Wkly. Rep. 2008, 57(December (49)):1329-1332.
4. CDC Influenza-testing and antiviral-agent prescribing practices-Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. Morb. Mortal. Wkly. Rep. 2008, 57(January (3)):61-65.
5. CDC Update: influenza activity-United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. Morb. Mortal. Wkly. Rep. 2009, 58(April (14)):369-374.
6. CDC Update: influenza activity-United States, August 30, 2009-March 27, and composition of the 2010-11 influenza vaccine. Morb. Mortal. Wkly. Rep. 2010, 59(April (14)):423-430.
7. CDC Issues Interim Recommendations for the Use of Influenza Antiviral Medications in the Setting of Oseltamivir Resistance among Circulating Influenza A (H1N1) Viruses, 2008-09 Influenza Season. [cited May 13, 2010], Available from: http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp%3FAlertNum=00279.
8. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., St George K., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 2009, 301(March (10)):1034-1041.
9. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network The emerging infections network: a new venture for the Infectious Diseases Society of America. Clin. Infect. Dis. 1997, 25(July (1)):34-36.
10. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., Bresee J.S., Cox N.J. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 2009, 58(July (RR-8)):1-52.
11. Katz M.A., Lamias M.J., Shay D.K., Uyeki T.M. Use of rapid tests and antiviral medications for influenza among primary care providers in the United States. Influenza Other Respir. Viruses 2009, 3(January (1)):29-35.
12. Ortiz J.R., Shay D.K., Liedtke L.A., Bresee J.S., Strausbaugh L.J. A national survey of the Infectious Diseases Society of America Emerging Infections Network concerning neuraminidase inhibitor prescription practices and pandemic influenza preparations. Clin. Infect. Dis. 2006, 43(August (4)):494-497.
13. Pandemic (H1N1) 2009. [cited May 13, 2010], available from http://www.who.int/csr/disease/swineflu/en/index.html.
14. Podewils L.J., Liedtke L.A., McDonald L.C., Hageman J.C., Strausbaugh L.J., Fischer T.K., Jernigan D.B., Uyeki T.M., Kuehnert M.J. A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin. Infect. Dis. 2005, 40(June (11)):1693-1696.
15. Rothberg M.B., Bonner A.B., Rajab M.H., Kim H.S., Stechenberg B.W., Rose D.N. Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. Clin. Infect. Dis. 2006, 42(January (1)):95-99.